Mulmit

Century Therapeutics, Inc.Century Therapeutics, Inc.

IPSC Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31109,164,000-17,269,000-9,580,000-0.14
2024-12-316,589,000-138,137,000-126,566,000-1.61
2023-12-312,235,000-146,546,000-136,673,000-2.3
2022-12-315,199,000-133,831,000-130,932,000-2.96

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-08Russotti GregorySee Remarks534
2026-09-08Carr DouglasSVP Finance & Operations254
2026-09-04Pfeiffenberger BrentPresident and CEO463
2026-08-14Pfeiffenberger BrentPresident and CEO31,172
2026-08-03Carr DouglasSVP Finance & Operations275
2026-06-12Russotti GregorySee Remarks2,584
2026-06-12Carr DouglasSVP Finance & Operations1,654
2026-06-11Cowan ChadChief Scientific Officer358
2026-06-11Pfeiffenberger BrentPresident and CEO13,849
2026-06-11Murphy Martin Patrick74,000
2026-06-11Lee Han Myung74,000
2026-06-11Riva Alessandro74,000

8-K events

FiledItems
2026-09-09Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-08-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-06-16Officer or director change
2026-06-12Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-08Other events · Financial statements and exhibits
2026-05-13Results of operations · Financial statements and exhibits
2026-03-26Other events · Financial statements and exhibits
2026-03-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.